295 related articles for article (PubMed ID: 25448108)
21. Mucosal immunization with recombinant heparin-binding haemagglutinin adhesin suppresses extrapulmonary dissemination of Mycobacterium bovis bacillus Calmette-Guérin (BCG) in infected mice.
Kohama H; Umemura M; Okamoto Y; Yahagi A; Goga H; Harakuni T; Matsuzaki G; Arakawa T
Vaccine; 2008 Feb; 26(7):924-32. PubMed ID: 18192091
[TBL] [Abstract][Full Text] [Related]
22. Comparing adjuvanted H28 and modified vaccinia virus ankara expressingH28 in a mouse and a non-human primate tuberculosis model.
Billeskov R; Christensen JP; Aagaard C; Andersen P; Dietrich J
PLoS One; 2013; 8(8):e72185. PubMed ID: 23977248
[TBL] [Abstract][Full Text] [Related]
23. Immunization with heat-killed Mycobacterium bovis bacille Calmette-Guerin (BCG) in Eurocine L3 adjuvant protects against tuberculosis.
Haile M; Schröder U; Hamasur B; Pawlowski A; Jaxmar T; Källenius G; Svenson SB
Vaccine; 2004 Mar; 22(11-12):1498-508. PubMed ID: 15063575
[TBL] [Abstract][Full Text] [Related]
24. Neonatal revaccination with Bacillus Calmette-Guérin elicits improved, early protection against Mycobacterium tuberculosis in mice.
Li W; Huang H; Hua W; Ben S; Liu H; Xu B; Xian Q; Tang Z; Shen H
Vaccine; 2012 May; 30(21):3223-30. PubMed ID: 22342709
[TBL] [Abstract][Full Text] [Related]
25. Activation of CD8 T cells by mycobacterial vaccination protects against pulmonary tuberculosis in the absence of CD4 T cells.
Wang J; Santosuosso M; Ngai P; Zganiacz A; Xing Z
J Immunol; 2004 Oct; 173(7):4590-7. PubMed ID: 15383593
[TBL] [Abstract][Full Text] [Related]
26. Comparison of immune responses of mice immunized with five different Mycobacterium bovis BCG vaccine strains.
Lagranderie MR; Balazuc AM; Deriaud E; Leclerc CD; Gheorghiu M
Infect Immun; 1996 Jan; 64(1):1-9. PubMed ID: 8557324
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of the Immunogenicity of Mycobacterium bovis BCG Delivered by Aerosol to the Lungs of Macaques.
White AD; Sarfas C; West K; Sibley LS; Wareham AS; Clark S; Dennis MJ; Williams A; Marsh PD; Sharpe SA
Clin Vaccine Immunol; 2015 Sep; 22(9):992-1003. PubMed ID: 26108288
[TBL] [Abstract][Full Text] [Related]
28. Chlamydia muridarum T-cell antigens formulated with the adjuvant DDA/TDB induce immunity against infection that correlates with a high frequency of gamma interferon (IFN-gamma)/tumor necrosis factor alpha and IFN-gamma/interleukin-17 double-positive CD4+ T cells.
Yu H; Jiang X; Shen C; Karunakaran KP; Jiang J; Rosin NL; Brunham RC
Infect Immun; 2010 May; 78(5):2272-82. PubMed ID: 20231405
[TBL] [Abstract][Full Text] [Related]
29. Increased pulmonary tumor necrosis factor alpha, interleukin-6 (IL-6), and IL-17A responses compensate for decreased gamma interferon production in anti-IL-12 autovaccine-treated, Mycobacterium bovis BCG-vaccinated mice.
Freches D; Romano M; Korf H; Renauld JC; Van Snick J; Uyttenhove C; Huygen K
Clin Vaccine Immunol; 2011 Jan; 18(1):95-104. PubMed ID: 21084465
[TBL] [Abstract][Full Text] [Related]
30. Lymphatic tracing and T cell responses following oral vaccination with live Mycobacterium bovis (BCG).
Dorer DE; Czepluch W; Lambeth MR; Dunn AC; Reitinger C; Aldwell FE; McLellan AD
Cell Microbiol; 2007 Feb; 9(2):544-53. PubMed ID: 17018037
[TBL] [Abstract][Full Text] [Related]
31. Subunit vaccine candidate AMM down-regulated the regulatory T cells and enhanced the protective immunity of BCG on a suitable schedule.
Luo Y; Jiang W; Da Z; Wang B; Hu L; Zhang Y; An R; Yu H; Sun H; Tang K; Tang Z; Wang Y; Jing T; Zhu B
Scand J Immunol; 2012 Mar; 75(3):293-300. PubMed ID: 22117839
[TBL] [Abstract][Full Text] [Related]
32. M.tuberculosis mutants lacking oxygenated mycolates show increased immunogenicity and protective efficacy as compared to M. bovis BCG vaccine in an experimental mouse model.
Hedhli D; Denis O; Barkan D; Daffé M; Glickman MS; Huygen K
PLoS One; 2013; 8(10):e76442. PubMed ID: 24146869
[TBL] [Abstract][Full Text] [Related]
33. Immune response to Mycobacterium bovis bacille Calmette Guérin infection in major histocompatibility complex class I- and II-deficient knock-out mice: contribution of CD4 and CD8 T cells to acquired resistance.
Ladel CH; Daugelat S; Kaufmann SH
Eur J Immunol; 1995 Feb; 25(2):377-84. PubMed ID: 7875199
[TBL] [Abstract][Full Text] [Related]
34. Immunogenicity and protective efficacy of DMT liposome-adjuvanted tuberculosis subunit CTT3H vaccine.
Teng X; Tian M; Li J; Tan S; Yuan X; Yu Q; Jing Y; Zhang Z; Yue T; Zhou L; Fan X
Hum Vaccin Immunother; 2015; 11(6):1456-64. PubMed ID: 25905680
[TBL] [Abstract][Full Text] [Related]
35. Difference in TB10.4 T-cell epitope recognition following immunization with recombinant TB10.4, BCG or infection with Mycobacterium tuberculosis.
Billeskov R; Grandal MV; Poulsen C; Christensen JP; Winther N; Vingsbo-Lundberg C; Hoang TT; van Deurs B; Song YH; Aagaard C; Andersen P; Dietrich J
Eur J Immunol; 2010 May; 40(5):1342-54. PubMed ID: 20186878
[TBL] [Abstract][Full Text] [Related]
36. Loss of anti-mycobacterial efficacy in mice over time following vaccination with Mycobacterium bovis bacillus Calmette-Guérin.
Ozeki Y; Hirayama Y; Takii T; Yamamoto S; Kobayashi K; Matsumoto S
Vaccine; 2011 Sep; 29(40):6881-7. PubMed ID: 21803102
[TBL] [Abstract][Full Text] [Related]
37. Exposure to Mycobacterium avium can modulate established immunity against Mycobacterium tuberculosis infection generated by Mycobacterium bovis BCG vaccination.
Flaherty DK; Vesosky B; Beamer GL; Stromberg P; Turner J
J Leukoc Biol; 2006 Dec; 80(6):1262-71. PubMed ID: 16968819
[TBL] [Abstract][Full Text] [Related]
38. Protective efficacy of intranasal vaccination with Mycobacterium bovis BCG against airway Mycobacterium tuberculosis challenge in mice.
Giri PK; Verma I; Khuller GK
J Infect; 2006 Nov; 53(5):350-6. PubMed ID: 16442629
[TBL] [Abstract][Full Text] [Related]
39. PD-1-PD-L1 pathway impairs T(h)1 immune response in the late stage of infection with Mycobacterium bovis bacillus Calmette-Guérin.
Sakai S; Kawamura I; Okazaki T; Tsuchiya K; Uchiyama R; Mitsuyama M
Int Immunol; 2010 Dec; 22(12):915-25. PubMed ID: 21047981
[TBL] [Abstract][Full Text] [Related]
40. Mycobacteria-Specific T Cells Are Generated in the Lung During Mucosal BCG Immunization or Infection With
Basile JI; Liu R; Mou W; Gao Y; Carow B; Rottenberg ME
Front Immunol; 2020; 11():566319. PubMed ID: 33193338
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]